The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Interventional Lung Disease Market Research Report 2025

Global Interventional Lung Disease Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1466098

No of Pages : 87

Ask Your Query
Synopsis
Interventional pulmonology is a relatively new field in pulmonary medicine. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest.
The global Interventional Lung Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional Lung Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional Lung Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interventional Lung Disease include Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, Cook Medical, Vygon, PENTAX Medical and Clarus Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional Lung Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Lung Disease.
Report Scope
The Interventional Lung Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Lung Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Lung Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Olympus
FUJIFILM
Becton, Dickinson and Company
Smiths Group
Cook Medical
Vygon
PENTAX Medical
Clarus Medical
HUGER Medical Instrument
Richard Wolf
Karl Storz
Taewoong Medical
ELLA - CS
Segment by Type
Bronchoscopes
Respiratory Endotherapy Devices
ENB Systems
Pleuroscopes
Other
Segment by Application
Hospital
Emergency Center
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interventional Lung Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interventional Lung Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Interventional Lung Disease Market Overview
1.1 Product Overview and Scope of Interventional Lung Disease
1.2 Interventional Lung Disease Segment by Type
1.2.1 Global Interventional Lung Disease Market Value Comparison by Type (2024-2030)
1.2.2 Bronchoscopes
1.2.3 Respiratory Endotherapy Devices
1.2.4 ENB Systems
1.2.5 Pleuroscopes
1.2.6 Other
1.3 Interventional Lung Disease Segment by Application
1.3.1 Global Interventional Lung Disease Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Emergency Center
1.3.4 Clinic
1.4 Global Interventional Lung Disease Market Size Estimates and Forecasts
1.4.1 Global Interventional Lung Disease Revenue 2019-2030
1.4.2 Global Interventional Lung Disease Sales 2019-2030
1.4.3 Global Interventional Lung Disease Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interventional Lung Disease Market Competition by Manufacturers
2.1 Global Interventional Lung Disease Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interventional Lung Disease Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interventional Lung Disease Average Price by Manufacturers (2019-2024)
2.4 Global Interventional Lung Disease Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interventional Lung Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interventional Lung Disease, Product Type & Application
2.7 Interventional Lung Disease Market Competitive Situation and Trends
2.7.1 Interventional Lung Disease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interventional Lung Disease Players Market Share by Revenue
2.7.3 Global Interventional Lung Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interventional Lung Disease Retrospective Market Scenario by Region
3.1 Global Interventional Lung Disease Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interventional Lung Disease Global Interventional Lung Disease Sales by Region: 2019-2030
3.2.1 Global Interventional Lung Disease Sales by Region: 2019-2024
3.2.2 Global Interventional Lung Disease Sales by Region: 2025-2030
3.3 Global Interventional Lung Disease Global Interventional Lung Disease Revenue by Region: 2019-2030
3.3.1 Global Interventional Lung Disease Revenue by Region: 2019-2024
3.3.2 Global Interventional Lung Disease Revenue by Region: 2025-2030
3.4 North America Interventional Lung Disease Market Facts & Figures by Country
3.4.1 North America Interventional Lung Disease Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interventional Lung Disease Sales by Country (2019-2030)
3.4.3 North America Interventional Lung Disease Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interventional Lung Disease Market Facts & Figures by Country
3.5.1 Europe Interventional Lung Disease Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interventional Lung Disease Sales by Country (2019-2030)
3.5.3 Europe Interventional Lung Disease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interventional Lung Disease Market Facts & Figures by Country
3.6.1 Asia Pacific Interventional Lung Disease Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interventional Lung Disease Sales by Country (2019-2030)
3.6.3 Asia Pacific Interventional Lung Disease Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Interventional Lung Disease Market Facts & Figures by Country
3.7.1 Latin America Interventional Lung Disease Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interventional Lung Disease Sales by Country (2019-2030)
3.7.3 Latin America Interventional Lung Disease Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interventional Lung Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Interventional Lung Disease Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interventional Lung Disease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interventional Lung Disease Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Interventional Lung Disease Sales by Type (2019-2030)
4.1.1 Global Interventional Lung Disease Sales by Type (2019-2024)
4.1.2 Global Interventional Lung Disease Sales by Type (2025-2030)
4.1.3 Global Interventional Lung Disease Sales Market Share by Type (2019-2030)
4.2 Global Interventional Lung Disease Revenue by Type (2019-2030)
4.2.1 Global Interventional Lung Disease Revenue by Type (2019-2024)
4.2.2 Global Interventional Lung Disease Revenue by Type (2025-2030)
4.2.3 Global Interventional Lung Disease Revenue Market Share by Type (2019-2030)
4.3 Global Interventional Lung Disease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interventional Lung Disease Sales by Application (2019-2030)
5.1.1 Global Interventional Lung Disease Sales by Application (2019-2024)
5.1.2 Global Interventional Lung Disease Sales by Application (2025-2030)
5.1.3 Global Interventional Lung Disease Sales Market Share by Application (2019-2030)
5.2 Global Interventional Lung Disease Revenue by Application (2019-2030)
5.2.1 Global Interventional Lung Disease Revenue by Application (2019-2024)
5.2.2 Global Interventional Lung Disease Revenue by Application (2025-2030)
5.2.3 Global Interventional Lung Disease Revenue Market Share by Application (2019-2030)
5.3 Global Interventional Lung Disease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Interventional Lung Disease Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Olympus
6.2.1 Olympus Corporation Information
6.2.2 Olympus Description and Business Overview
6.2.3 Olympus Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Olympus Interventional Lung Disease Product Portfolio
6.2.5 Olympus Recent Developments/Updates
6.3 FUJIFILM
6.3.1 FUJIFILM Corporation Information
6.3.2 FUJIFILM Description and Business Overview
6.3.3 FUJIFILM Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 FUJIFILM Interventional Lung Disease Product Portfolio
6.3.5 FUJIFILM Recent Developments/Updates
6.4 Becton, Dickinson and Company
6.4.1 Becton, Dickinson and Company Corporation Information
6.4.2 Becton, Dickinson and Company Description and Business Overview
6.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Becton, Dickinson and Company Interventional Lung Disease Product Portfolio
6.4.5 Becton, Dickinson and Company Recent Developments/Updates
6.5 Smiths Group
6.5.1 Smiths Group Corporation Information
6.5.2 Smiths Group Description and Business Overview
6.5.3 Smiths Group Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Smiths Group Interventional Lung Disease Product Portfolio
6.5.5 Smiths Group Recent Developments/Updates
6.6 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cook Medical Interventional Lung Disease Product Portfolio
6.6.5 Cook Medical Recent Developments/Updates
6.7 Vygon
6.6.1 Vygon Corporation Information
6.6.2 Vygon Description and Business Overview
6.6.3 Vygon Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vygon Interventional Lung Disease Product Portfolio
6.7.5 Vygon Recent Developments/Updates
6.8 PENTAX Medical
6.8.1 PENTAX Medical Corporation Information
6.8.2 PENTAX Medical Description and Business Overview
6.8.3 PENTAX Medical Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PENTAX Medical Interventional Lung Disease Product Portfolio
6.8.5 PENTAX Medical Recent Developments/Updates
6.9 Clarus Medical
6.9.1 Clarus Medical Corporation Information
6.9.2 Clarus Medical Description and Business Overview
6.9.3 Clarus Medical Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Clarus Medical Interventional Lung Disease Product Portfolio
6.9.5 Clarus Medical Recent Developments/Updates
6.10 HUGER Medical Instrument
6.10.1 HUGER Medical Instrument Corporation Information
6.10.2 HUGER Medical Instrument Description and Business Overview
6.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HUGER Medical Instrument Interventional Lung Disease Product Portfolio
6.10.5 HUGER Medical Instrument Recent Developments/Updates
6.11 Richard Wolf
6.11.1 Richard Wolf Corporation Information
6.11.2 Richard Wolf Interventional Lung Disease Description and Business Overview
6.11.3 Richard Wolf Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Richard Wolf Interventional Lung Disease Product Portfolio
6.11.5 Richard Wolf Recent Developments/Updates
6.12 Karl Storz
6.12.1 Karl Storz Corporation Information
6.12.2 Karl Storz Interventional Lung Disease Description and Business Overview
6.12.3 Karl Storz Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Karl Storz Interventional Lung Disease Product Portfolio
6.12.5 Karl Storz Recent Developments/Updates
6.13 Taewoong Medical
6.13.1 Taewoong Medical Corporation Information
6.13.2 Taewoong Medical Interventional Lung Disease Description and Business Overview
6.13.3 Taewoong Medical Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Taewoong Medical Interventional Lung Disease Product Portfolio
6.13.5 Taewoong Medical Recent Developments/Updates
6.14 ELLA - CS
6.14.1 ELLA - CS Corporation Information
6.14.2 ELLA - CS Interventional Lung Disease Description and Business Overview
6.14.3 ELLA - CS Interventional Lung Disease Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ELLA - CS Interventional Lung Disease Product Portfolio
6.14.5 ELLA - CS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interventional Lung Disease Industry Chain Analysis
7.2 Interventional Lung Disease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interventional Lung Disease Production Mode & Process
7.4 Interventional Lung Disease Sales and Marketing
7.4.1 Interventional Lung Disease Sales Channels
7.4.2 Interventional Lung Disease Distributors
7.5 Interventional Lung Disease Customers
8 Interventional Lung Disease Market Dynamics
8.1 Interventional Lung Disease Industry Trends
8.2 Interventional Lung Disease Market Drivers
8.3 Interventional Lung Disease Market Challenges
8.4 Interventional Lung Disease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock